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In vertebrate embryos, the earliest definitive marker for the neural plate, which will give rise to the entire central
nervous system, is the transcription factor Sox2. Although some of the extracellular signals that regulate neural plate
fate have been identified, we know very little about the mechanisms controlling Sox2 expression and thus neural plate
identity. Here, we use electroporation for gain- and loss-of-function in the chick embryo, in combination with
bimolecular fluorescence complementation, two-hybrid screens, chromatin immunoprecipitation, and reporter assays
to study protein interactions that regulate expression of N2, the earliest enhancer of Sox2 to be activated and which
directs expression to the largest part of the neural plate. We show that interactions between three coiled-coil domain
proteins (ERNI, Geminin, and BERT), the heterochromatin proteins HP1a and HP1c acting as repressors, and the
chromatin-remodeling enzyme Brm acting as activator control the N2 enhancer. We propose that this mechanism
regulates the timing of Sox2 expression as part of the process of establishing neural plate identity.
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Introduction
Sox2 is a transcription factor that plays multiple critical
roles during embryonic development in vertebrates. In
embryonic stem (ES) cells, as well as in adult central nervous
system (CNS) stem cells, Sox2 expression is required for the
maintenance of multipotency and for the ability of cells to
self-renew [1]. Sox2 is also expressed in cells that retain their
ability to proliferate and/or acquire glial fates, whereas it is
down-regulated in cells that become postmitotic and differ-
entiate into neurons [2–4]. In addition, it is also transiently
expressed outside the CNS in cranial sensory organs derived
from the placodes and in subsets of peripheral nervous
system (PNS) cells [5,6].
In all vertebrates studied to date, Sox2 is also a general
marker for the very early developing neural plate. In the
chick, for example, Sox2 expression starts at the late primitive
streak stage (stages 4–4þ [7]) in the future neural territory
[8,9]. A morphologically recognizable neural plate only
becomes visible after the beginning of Sox2 expression [8].
Importantly, Sox2 function is required for development of
the neural plate [10]. Time-course experiments have shown
that induction of Sox2 requires the same period of exposure
to organizer-derived signals (the tissue responsible for
inducing the neural plate in the normal embryo [11–13]) as
is required to induce a mature neural plate [14–17]. For these
reasons, Sox2 is considered to be the earliest deﬁnitive marker
for the neural plate [18,19].
The complex expression proﬁle of Sox2 is controlled by
multiple regulatory elements, each responsible for directing
expression to a speciﬁc subset of expression sites. A very
compelling analysis of the noncoding regions of Sox2 in the
chick embryo [20] revealed as many as 25 distinct conserved
enhancers, of which two account for the expression of this
gene in the early neural plate at stages 4þ–5. One of these
enhancers, named N2, is responsible for the initial expression
(stage 4–4þ) and is activated in a large domain corresponding
to the entire forebrain/midbrain and most of the hindbrain.
The other, N1, drives expression in the future caudal
hindbrain and spinal cord and is activated a little later
(around stage 5) [20,21]. To understand the processes that
deﬁne the neural plate, it is essential to understand how the
activity of these two elements, and especially N2, is regulated
in the embryo.
Analysis of the N2 enhancer reveals multiple putative
binding sites for known transcription factors [20,21]. How-
ever, the spatial and temporal expression patterns of these
factors do not provide an obvious explanation for the time of
onset of Sox2 expression in normal development (unpub-
lished data). Furthermore, to date, no single secreted factor
or any combination thereof has been found to induce either
Sox2 expression or a neural plate in competent cells not
normally fated to form part of the neural plate [13,19]. We
therefore directed our attention to nuclear factors that might
regulate this enhancer. Here, we provide evidence that a
group of coiled-coil proteins interact with each other and
with chromatin-remodeling factors and heterochromatin
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proteins to regulate the activity of the N2 enhancer. We
propose that this is part of a mechanism that regulates the
time of onset of expression of Sox2 in the nascent neural
plate.
Results
HP1a Inhibits Sox2 Expression through a Brm-Dependent
Mechanism
A recent study [22] using the P19 cell line demonstrated
that the chromatin-remodeling enzyme Brahma (Brm) can
activate Sox2 by binding directly to the N2 enhancer. Is
Brahma also involved in regulating Sox2 expression in the
normal embryo? To test this, we introduced a mutated
version of Brahma (BrmK755R, which does not bind ATP and is
therefore unable to remodel chromatin [23]) by electro-
poration into the prospective neural plate of embryos at stage
3–3þ. This resulted in strong inhibition of Sox2 expression in
the electroporated domain (Figure 1A and 1B; 5/6), unlike
controls electroporated with green ﬂuorescent protein (GFP)
(Figure 1C and 1D; 0/5 expressing).
However, Brm is expressed ubiquitously in the embryo [24];
what mechanisms prevent premature expression of Sox2? A
good candidate is the transcriptional repressor HP1a, which
binds directly to Brahma-related proteins at a highly
conserved site [25] and which is also ubiquitously expressed
in early embryos (Figure 2). Consistent with this, over-
expression of HP1a in the neural plate represses Sox2 (Figure
1E and 1F; 3/3). Could HP1a be an endogenous inhibitor of
Sox2 expression? To address this, we took advantage of the
fact that both the chromoshadow domain and the chromo-
domain are necessary for the function of HP1 proteins
[26,27]: targeting to chromatin requires interaction of the
chromoshadow domain with a chromatin-tethered partner, as
well as binding of the chromodomain to a methylated Lys9 of
histone H3 [28]. We therefore made a dominant-negative
form of HP1a (DHP1a) consisting of its isolated chromosh-
adow domain (which can bind to Brahma-related proteins but
lacks repressor activity [25]). When DHP1a is misexpressed as
a line extending from the neural plate into the peripheral,
nonneural ectoderm (see Materials and Methods, ‘‘Design of
assays’’), Sox2 is induced (Figure 1G and 1H; 6/7), whereas
similar electroporation of GFP has no effect (Figure 1I and 1J;
0/8). This suggests that HP1a activity is required to prevent
expression of Sox2 in the nonneural ectoderm.
In embryos in which DHP1a was expressed as a line, we
observed that Sox2 was up-regulated, not only in the
embryonic nonneural ectoderm (prospective epidermis), but
also in the more peripheral area opaca epiblast (extraem-
bryonic ectoderm) (Figure 1G). We were surprised by this
observation because until now, various factors (such as bone
morphogenetic protein [BMP] antagonists [16,17,19]) have
been described that can expand the neural plate domain, but
never as far as the extraembryonic epiblast, and none can
induce a separate domain of Sox2 expression in this region.
The only treatment described to date that can induce neural
markers in the area opaca is a graft of the organizer, Hensen’s
node, which is able to generate a complete, patterned nervous
system in this region [13,29–32]. These observations deﬁne
the area opaca as a particularly rigorous location in which to
test for the neural inducing ability of factors (see Materials
and Methods, ‘‘Design of assays’’). Electroporation of DHP1a
in this region dramatically induces Sox2, showing that HP1a
normally represses Sox2 expression (Figure 1K and 1L; 8/8). In
contrast, electroporation of GFP in the same region has no
effect (Figure 1M and 1N; 0/10). As an additional control,
since HP1a may have more general activity as a transcrip-
tional repressor, we also tested whether DHP1a can also
induce other early embryonic genes using Brachyury, a marker
for mesoderm expressed at this stage of development. It did
not (Figure 1O and 1P; 0/3). This result also conﬁrms that the
induction of Sox2 is direct, rather than a consequence of prior
induction of mesoderm by DHP1a. Likewise, electroporation
of BrmK755R or Brm had no effect on neural or mesoderm
markers (0/5 for each; unpublished data). To test whether the
inducing activity of DHP1a requires Brahma, we introduced
DHP1a together with BrmK755R. This combination fails to
induce Sox2 (Figure 1Q and 1R; 0/12), suggesting that HP1a
normally inhibits Sox2 expression through a Brm-dependent
mechanism (Figure 1S).
Geminin Induces Sox2 by a Brm-Dependent Mechanism
In Xenopus, the gene encoding the coiled-coil protein
Geminin is expressed in the early prospective neural plate,
and its misexpression induces neural markers [33]. More
recently, it has been shown that Geminin interacts genetically
with Drosophila Brahma, that it binds directly to its vertebrate
homologs Brg1 and Brm (at the same site as does HP1a), and
that Geminin knock-down abolishes Sox2 expression [25,34].
Could Geminin be responsible for releasing the repression of
Brm activity by HP1a? To test this, we cloned the chick
homolog of Geminin. Before and during early gastrulation,
Geminin is expressed in a large domain, which then (from
stages 4–4þ) becomes restricted to the neural plate (Figure 3).
The early expression of chick Geminin resembles that of ‘‘pre-
neural’’ genes (such as Sox3, ERNI, and Churchill), which
precede the initiation of Sox2 expression and which are
induced by ﬁbroblast growth factor 8 (FGF8) [8,9,35,36]. We
therefore tested whether FGF can also induce Geminin.
Indeed, Geminin can be induced by FGF8-soaked beads (9/10;
Figure 3H, arrow), but not by control beads (0/10; Figure 3H,
arrowhead).
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Author Summary
During early development, when the embryo has three layers of
cells (ectoderm, mesoderm, and endoderm), a region of the
ectoderm called the neural plate becomes specified to generate
the entire nervous system. One of the earliest molecular markers for
the neural plate is the transcription factor Sox2, which is critical for
cells to acquire their neural fates and also defines neural progenitor
character. We know very little about the intracellular mechanisms by
which the neural plate cells acquire these fates. Here, we show that
recruitment of transcriptional repressors to chromatin-remodeling
complexes regulate the onset of Sox2 expression. Competitive
interactions between three proteins, ERNI, BERT, and Geminin,
modulate the choice of repressors and regulate Sox2 expression.
During gastrulation, when the three embryonic cell layers form, ERNI
recruits the repressor HP1c to prevent Geminin from activating Sox2
prematurely. By the end of gastrulation, this repression is counter-
acted by competitive binding of BERT to ERNI and Geminin, causing
activation of Sox2. We propose that this mechanism regulates the
timing of Sox2 activation in the very early neural plate and thus
helps to define the domain that will give rise to the nervous system.
When misexpressed as a line extending laterally from the
neural plate, Geminin strongly induces ectopic Sox2 (Figure 4A
and 4B; 8/8). Geminin can also strongly induce Sox2
expression when introduced into the extraembryonic epiblast
(Figure 4C and 4D; 20/20). To test whether this induction
requires the chromatin-remodeling activity of Brm, we
cointroduced Geminin and BrmK755R: the mutated chromatin
remodeler abolishes the induction of Sox2 by Geminin (Figure
Figure 1. HP1a Inhibits Sox2
(A, C, E, G, I, K, M, and Q) Embryos electroporated with BrmK755R (A), GFP (C), or HP1a (E) in the neural plate, DHP1a (G) or GFP (I) in the nonneural
ectoderm, and DHP1a (K), GFP (M), and DHP1a together with BrmK755R (Q) in the extra-embryonic epiblast and stained for Sox2 (purple).
(B, D, F, H, J, L, N, and R) Subsequent staining for GFP (brown) marks the electroporated cells in the same embryos.
(O and P) Embryo electroporated with DHP1a in the extra-embryonic epiblast and stained for Brachyury (purple) (O). In (P), the same embryo is stained
for GFP (brown), which marks the electroporated cells.
(S) These results suggest that HP1a bound to Brm on the N2 enhancer inhibits expression of Sox2.
In this and subsequent figures, the construct electroporated is indicated on the lower left, and the probes used for in situ hybridization and antibody
staining are on the lower right of the panels.
doi:10.1371/journal.pbio.0060002.g001
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4E and 4F; 0/15), suggesting that Brm activity is required for
Sox2 induction by Geminin. Together, these results suggest
that early in development Sox2 expression is constitutively
repressed by the presence of HP1a bound to Brm at the N2
enhancer of Sox2, and that later in development, FGF may
release this inhibition through induction of Geminin, which
competes HP1a away from the protein complex (Figure 4G).
ERNI Inhibits Sox2 Induction by Geminin
Geminin is already expressed at the beginning of gastrula-
tion (Figure 3), long before Sox2 (which appears at stage 4
[8,9]), suggesting that an additional mechanism must exist to
prevent premature Sox2 activation. A good candidate for this
repression is ERNI, which is broadly expressed in the epiblast
at early stages but is rapidly down-regulated from the
prospective neural plate at stage 4þ [36], around the time
when Sox2 starts to be expressed. To test whether ERNI can
inhibit the induction of Sox2 by Geminin, we cointroduced
them into the area opaca: ERNI does indeed inhibit the
induction of Sox2 by Geminin (6/14 with very weak induction,
8/14 with no induction; Figure 5A–5C).
Mechanism of Repression by ERNI
ERNI and Geminin bind through their coiled-coil domains.
By what mechanism does ERNI exert its inhibition? ERNI
contains two putative functional domains: a coiled-coil
domain in its N-terminal half (amino acids [aa] 79–137) and
a likely phosphorylation site (aa 222–228) [36]. Since coiled-
coil domains are often involved in protein–protein inter-
actions, and since both ERNI and Geminin contain such a
domain, we tested the possibility that ERNI can bind to
Geminin and/or to itself. As no antibodies to ERNI or chick
Geminin are available, precluding coimmunoprecipitation
assays, we used bimolecular ﬂuorescence complementation
(BiFCo), a powerful technique allowing protein interactions
to be visualized within living cells [37,38]. All possible
combinations of ERNI and Geminin fusions to the N- and
C-termini of the yellow ﬂuorescent protein (YFP) variant
Venus [39] were transfected pairwise into COS cells so that
whenever an interaction occurs, ﬂuorescence is seen. This
revealed that ERNI and Geminin can associate as homo- or
heterodimers, unlike several controls, including other coiled-
coil proteins (Table 1). The same results were obtained in vivo
when the constructs are electroporated into early chick
embryos (unpublished data). To test whether this interaction
occurs through the coiled-coil domain, we repeated this
experiment using the isolated coiled-coil domains of ERNI
and Geminin. This revealed that the isolated coiled-coil
domains of ERNI and Geminin are sufﬁcient for their homo-
and heterodimerization (Table 1).
The C-terminus of ERNI is important for its function. Since
ERNI lacks any recognizable repression motif, it is possible
that it antagonizes the activity of Geminin by recruiting other
Figure 2. Expression of HP1a during Normal Development
(A–C) Before and during gastrulation, HP1a is expressed throughout the embryo although its expression becomes gradually stronger in the prospective
neural plate.
(D–I) At the end of gastrulation (D), HP1a expression in the ectoderm becomes restricted in the prospective neural plate, where it gets stronger in
subsequent stages (E–I) while it disappears from the nonneural ectoderm and the extra-embryonic epiblast.
The number on each panel represents the embryonic stage according to Eyal-Giladi and Kochav [60] for pre-primitive streak stages (in Roman
numerals), and Hamburger and Hamilton [7] for later stages (Arabic numerals).
doi:10.1371/journal.pbio.0060002.g002
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proteins that interact with regions outside the coiled-coil
domain (which is involved in binding to Geminin) (Figure
5C). If so, constructs lacking regions outside the coiled-coil
domain should still bind to Geminin but fail to recruit the
repressor(s), therefore acting as dominant-negative forms. To
test this, we misexpressed the isolated coiled-coil (ERNIcc) by
electroporation in late primitive streak stage chick embryos.
This induces strong expression of Sox2 (Figure 6A and 6B; 12/
12), unlike full-length ERNI (Figure 6C and 6D; 0/8) or GFP
alone (Figure 6E and 6F; 0/8). ERNIcc did not induce
expression of other markers (Brachyury (0/6), Chordin (0/4), or
BMP4 (0/5); unpublished data), conﬁrming that the induction
of Sox2 by ERNIcc is direct and speciﬁc. Misexpression of
ERNI containing a point mutation in the putative phosphor-
ylation site (ERNIY228F) has the same effect as misexpression
of the isolated coiled-coil domain (Figure 6G and 6H; 9/9),
suggesting that ERNI phosphorylation is important for its
function.
HP1c binds to the C-terminus of ERNI and is required for
repression of Sox2. The above results predict that ERNI
might inhibit Sox2 by recruiting one or more inhibitory
proteins to the complex (Figure 5C). To identify such an
inhibitor, expressed at very early stages of development, we
took advantage of the fact that ERNI is also strongly
expressed in undifferentiated chicken embryonic stem (cES)
cells (where it was identiﬁed as ENS-1 [40]). We therefore
undertook a two-hybrid screen using ENS-1 as bait and a
cDNA library from undifferentiated cES cells. This identiﬁed,
among several candidates, CHCB2, the chick homolog of
HP1c, a chromatin modiﬁer with repressor activity [41]
(Figure 7A). HP1c is related to HP1a but does not bind
directly to Brahma-related proteins [25]. Further two-hybrid
assays using an ERNI/ENS-1 clone conﬁrmed (see above and
Table 1) that ERNI can form homodimers and that this
interaction requires the coiled-coil domain. In contrast,
interaction with HP1c is mediated by a short sequence
(HP1-box, PxVxL [28]) close to the C-terminus of ERNI
(Figure 7A and 7B). The related protein HP1b does not bind
signiﬁcantly to ERNI in the same assay (unpublished data).
HP1c interacts with ERNI through the chromoshadow
domain [42,43] of the former (unpublished data). To conﬁrm
these interactions by an independent method, we used BiFCo
in cES cells, which showed that HP1c can bind to full-length
ERNI, but not to ERNI with a mutated HP1-box (Table 1). We
also used this method to test whether ERNI can bind to HP1a:
no signiﬁcant binding was seen (unpublished data). These
ﬁndings suggest that ERNI inhibits Sox2 expression by
binding to Geminin through their respective coiled-coil
domains and by speciﬁc recruitment of the HP1c repressor
through a C-terminal HP1-box.
These ﬁndings predict that a dominant-negative form of
HP1c (comprising the chromoshadow domain but lacking the
chromodomain, which is required for repression [26–28])
should be able to relieve the inhibition by ERNI of Sox2
induction by Geminin (see above and Figure 5A–5C). To test
this, we coelectroporated Geminin and ERNI together with the
Figure 3. Expression of Chick Geminin during Normal Development and Its Regulation by FGF
(A–G) Geminin is expressed in the embryonic epiblast from pre-primitive streak stages (A). As the embryo develops, its expression becomes restricted to
the neural plate, where it intensifies (B–G).
(H) An FGF-soaked bead up-regulates Geminin in the extra-embryonic epiblast (arrow); a control bead has been grafted on the contralateral side
(arrowhead). Embryo stages as for Figure 2.
doi:10.1371/journal.pbio.0060002.g003
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isolated chromoshadow domain of HP1c (DHP1c) into the
area opaca. This combination of factors induces Sox2 (Figure
7C and 7D; 7/8), suggesting that HP1c is indeed required for
the inhibitory activity of ERNI (Figure 7E).
Is HP1c expressed at the right time and place to play a role
in regulating the onset of Sox2 expression? In situ hybrid-
ization reveals low-level, ubiquitous expression from early
primitive streak stages, increasing in the prospective neural
epiblast from stage 3þ–4 (Figure 8).
BERT, an Endogenous ERNI Antagonist
The above ﬁndings are consistent with the idea that ERNI
normally functions to repress Sox2 expression at very early
stages of development. However, it is unlikely that down-
regulation of ERNI transcription is sufﬁcient to relieve this
inhibition because Sox2 expression begins at stages 4–4þ [7],
when some ERNI transcripts can still be detected within the
prospective neural plate [36]. Therefore, an endogenous
inhibitor is likely to exist whose expression should begin at
around this time (stage 4–4þ). To identify such an inhibitor, a
two-hybrid screen was performed using ERNI as bait and a
library of cDNAs from stage 3–6 chick embryos (Figure 9A).
Only one partner was found, encoding a small coiled-coil
domain protein which we named BERT (Figure 9B). An
equivalent human protein (SCOCO, corresponding to the
fragment shown in bold in Figure 9B) was previously isolated
as a partner of human ARL1, a component of the Golgi
apparatus [44], and a nematode homolog (unc69) was found to
be essential for neural development [45]. BERT is expressed
ubiquitously at low levels at all stages, but is up-regulated
speciﬁcally in the prospective neural plate from stage 4–4þ
(Figure 10), just prior to when Sox2 expression appears [8,9].
When misexpressed as a line across the nonneural epiblast,
BERT acts like the dominant-negative ERNI constructs: it
induces strong expression of Sox2 (Figure 9C and 9D; 15/15),
which also acquires a neural plate-like morphology (Figure
Figure 4. Geminin Induces Sox2
(A–F) Embryos electroporated with Geminin (Gem) in the nonneural ectoderm (A) and Geminin (C) or Geminin together with BrmK755R (BrmDN) (E) in the
extra-embryonic epiblast and stained for Sox2 (purple). Subsequent staining for GFP (brown) marks the electroporated cells in the same embryos (B),
(D), and (F).
(G) We propose that Geminin displaces HP1a from its binding site on Brm, releasing its inhibition on Sox2 expression.
doi:10.1371/journal.pbio.0060002.g004
Figure 5. ERNI Blocks Induction of Sox2 by Geminin
(A and B) Embryo electroporated with Geminin and ERNI in the extraembryonic epiblast and stained for Sox2 (A) and GFP (B) to mark the electroporated
cells.
(C) We propose that ERNI inhibits the induction of Sox2 by Geminin.
doi:10.1371/journal.pbio.0060002.g005
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9D9: note that the thickened ectoderm characteristic of the
neural plate has greatly expanded on the electroporated side;
see arrowhead on right). Mesodermal markers (Brachyury,
Chordin, and BMP4; 0/5, 0/4, 0/4, respectively; unpublished
data) are not induced, showing that this expansion of the
neural plate is a direct effect. These ﬁndings indicate that
BERT has an activity compatible with it being an endogenous
antagonist of ERNI, regulating not only Sox2 expression, but
also the onset of neural plate development. To conﬁrm this,
we examined the effects of coexpressing BERT with Gem-
ininþERNI (which does not induce Sox2; see above and Figure
5A and 5B) in the area opaca. Indeed, when all three
constructs are cointroduced, induction of Sox2 is seen (12/
12; Figure 9E and 9F).
Is BERT required to control the onset of Sox2 expression in
the neural plate? To address this, we designed a ﬂuorescein-
labeled Morpholino oligonucleotide (MO) to the 59 end of the
coding sequence (see Materials and Methods) and introduced
this (together with GFP) by electroporation into the
prospective neural plate at stage 3–3þ and examined Sox2
expression at stages 4þ–5. BERT-MO caused down-regulation
of Sox2 expression in this domain (Figure 9G and 9H; 5/6),
unlike control MO (Figure 9I and 9J; 0/5). Staining of BERT-
MO–electroporated embryos with an antibody against BERT/
SCOCO (see Materials and Methods) conﬁrmed that the MO
does indeed inhibit translation of BERT protein (Figure 9K)
in the electroporated domain (Figure 9L). Together, these
ﬁndings implicate BERT as an endogenous antagonist of
ERNI, required to regulate the onset of Sox2 expression in the
neural plate.
From the results presented above, the evidence that BERT
binds to ERNI directly is based entirely on the two-hybrid
screen used to isolate BERT. To conﬁrm that the two proteins
can interact physically, we used BiFCo assays, which further
revealed that BERT, Geminin, and ERNI all bind to each
other through their coiled-coil domains (Figure 11 and Table
1). This ﬁnding raises the possibility that BERT disrupts
Geminin-ERNI dimers by binding to both proteins, thus
removing ERNI-HP1c from the complex to activate Sox2
(Figure 9M). To test this further, we used BiFCo competition
assays (Figure 12). When BERT is added to Geminin-Venus
(N)þERNI-Venus(C), ﬂuorescence is lost (Figure 12A and
12B). When Dlx5 is used as a control instead of BERT in this
Table 1. Protein–Protein Interactions Confirmed by BiFCo
Protein Geminin ERNI BERT Gem-cca ERNI-ccb ERNImutc
Geminin þþ þþþ þþþþþ NA NA NA
ERNI þþþ þ þþþ NA NA NA
BERT þþþþþ þþþ þþþ þþþþþ þþþ NA
Gem-cc NA NA þþþþþ þþþ þþþ NA
ERNI-cc NA NA þþþ þþþ þþþ NA
Dlx-5    NA NA NA
E2F3    NA NA NA
HP1c NA þþþ NA NA NA 
Number of plus signs (þ) denotes strength of interaction between different proteins fused
to the N- or C-terminus of YFP-Venus, estimated by the relative intensity of the
fluorescent signal. Dlx5 (a nuclear protein) and E2F3 (another nuclear protein with a
coiled-coil domain) were used as controls.
aCoiled-coil domain of Geminin.
bCoiled-coil domain of ERNI.
cERNI with a point mutation in the HP1-box.
doi:10.1371/journal.pbio.0060002.t001
Figure 6. Mutated Forms of ERNI Induce Sox2
(A, C, E, and G) Embryos electroporated with the isolated coiled-coil domain of ERNI (ERNIcc) (A), ERNI (C), GFP (E), or ERNIY228F (G) in the nonneural
ectoderm and stained for Sox2 (purple).
(B, D, F, and H) Subsequent staining for GFP (brown) marks the electroporated cells in the same embryos.
doi:10.1371/journal.pbio.0060002.g006
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assay, there is no effect (Figure 12C). Conversely, when BERT-
Venus(C) is added to Geminin-Venus(N)þERNI, ﬂuorescence
is generated (Figure 12D and 12E), and this is not mimicked
by addition of Dlx5-Venus(C) (Figure 12F). Likewise, when
BERT-Venus(C) is added to GemininþERNI-Venus(N), ﬂuo-
rescence is produced (Figure 12G and 12H), which is not
mimicked by the use of Dlx5-Venus(C) instead of BERT-
Venus(C) (Figure 12I). Together, these ﬁndings support the
idea that BERT can disrupt Geminin-ERNI heterodimers by
binding to both proteins.
The Protein Complex Regulates the Activity of the N2
Enhancer of Sox2
The experiments described above tested the protein–
protein interactions and their effects on Sox2 expression,
but their physical association with the N2 enhancer was
Figure 7. ERNI Inhibits Sox2 through HP1c
(A) A two-hybrid screen reveals that HP1c interacts with the C-terminus of ERNI:þþ,þ, or indicates growth induced by interaction of ENS-1/ERNI (E)
with HP1c/CHCB2 or with itself. Partially deleted or HP1-box–mutated forms are indicated. HP1c-CSD: carboxy-terminal 87 aa of HP1c containing the
chromoshadow domain (CSD).
(B) Partial amino acid sequence of ENS-1/ERNI: the pentapeptide PXVXL, necessary for specific interaction with the CSD of HP1c/CHCB2, is in bold.
(C) Embryo electroporated with Geminin, ERNI, and DHP1c in the extra-embryonic epiblast (G) and stained for Sox2 (purple).
(D) The same embryo after staining for GFP (brown) to mark electroporated cells.
(E) We propose that ERNI inhibits Sox2 expression by recruiting HP1c to the N2 enhancer.
doi:10.1371/journal.pbio.0060002.g007
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extrapolated from published results in a cultured cell line,
unrelated to the early neural plate [22]. To test whether these
interactions can regulate Sox2 expression directly at the N2
enhancer, we coelectroporated a reporter construct consist-
ing of the N2 enhancer and a minimal TK promoter [20]
driving expression of LacZ together with either Geminin
alone, with GemininþERNI, or with GemininþERNIþBERT, into
the extraembryonic epiblast. No expression of the reporter
was seen when it was coelectroporated with the control
construct pCAb-GFP (Figure 13A and 13B; 0/16) or with
GemininþERNI (unpublished data; 0/6). However, expression
was induced by both Geminin (unpublished data; 6/6) and by
GemininþERNIþBERT (Figure 13C and 13D; 5/5). This shows
that ERNI can block the activity of the N2 enhancer of Sox2
and that BERT inhibits this.
Finally, to conﬁrm that these proteins do indeed interact
physically with the N2 enhancer, we conducted chromatin
immunoprecipitation (ChIP) assays using chromatin ex-
tracted from embryonic day (E)7.5 mouse embryos and an
antibody against mouse Geminin. The antibody speciﬁcally
precipitates the N2 enhancer of Sox2 (Figure 13E, lane 3),
unlike control experiments performed either without chro-
matin (Figure 13E, lane 1) or without anti-Geminin antibody
(Figure 13E, lane 2). These ﬁndings demonstrate that
Geminin does indeed associate physically with the N2
enhancer of Sox2 in vivo at an appropriate stage in develop-
ment.
Discussion
Sox2 is an important gene that plays multiple roles in
development especially in controlling cell fate and prolifer-
ation. Its expression pattern is complex and regulated by
multiple noncoding elements [20,21]. In the normal embryo,
one of the earliest conserved sites of expression is the nascent
neural plate, where Sox2 constitutes the earliest deﬁnitive
marker for this tissue. It is therefore of particular interest to
understand the mechanisms that regulate the location and
timing of expression of this gene in the neural plate, as this
process is critical for normal nervous system development.
Here, we propose that interactions between several coiled-
coil proteins, heterochromatin proteins, and chromatin-
remodeling molecules regulate the time of onset of Sox2
expression in the chick neural plate.
A Simple Model
The most parsimonious model to explain our ﬁndings in
terms of how Sox2 expression is regulated in the early neural
plate comprises the four steps shown in Figures 1S, 4G, 7E,
and 9M. Since Brm and HP1a are expressed ubiquitously ([24]
and results from the present study), we propose that there is a
basal state in which Brm is bound to the N2 enhancer of Sox2
[22], but the latter is not expressed because the repressor
HP1a occupies the chromoshadow-binding domain of Brm
(Figure 1S). Early in development, FGF activity induces both
ERNI [18,36] and Geminin (this study) in the epiblast. Geminin
binds to the chromoshadow-binding domain of Brm, displac-
Figure 8. Expression of HP1c during Normal Development
(A) Before primitive streak formation, HP1c is expressed in the extra-embryonic epiblast.
(B–D) When the primitive streak forms, HP1c expression appears in the embryonic epiblast where it gradually becomes stronger in the prospective
neural plate.
(E–I) At the end of gastrulation (E), its expression in the ectoderm becomes restricted in the prospective neural plate, where it gets stronger at
subsequent stages (F–I), while it disappears from the nonneural ectoderm and extra-embryonic epiblast.
doi:10.1371/journal.pbio.0060002.g008
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ing HP1a (Figure 4G). However, the interaction of ERNI with
Geminin recruits the transcriptional repressor HP1c, thus
continuing to prevent premature expression of Sox2 in the
epiblast (Figure 7E). Later in development (stage 4–4þ), BERT
is up-regulated within the neural plate, where it binds to both
ERNI and Geminin and displaces ERNI-HP1c complexes away
from Brm, freeing the latter to activate N2 and thus Sox2
expression (Figure 9M). At around the same time, ERNI
transcription starts to be down-regulated in the neural plate.
This model accommodates all of our results and those in the
Figure 9. BERT Releases Geminin from the Inhibition of ERNI
(A) Representative colonies from the two-hybrid screen (left to right): positive (þ) control, negative () control, ERNIþBERT (E-B), ERNIccþBERT (Ecc-B),
ERNI without coiled-coil domainþ BERT (EDcc-B), and BERT alone (B).
(B) Amino acid sequence of BERT. The sequence originally isolated is shown in bold; the rest encodes a putative upstream exon.
(C–F) Embryos electroporated with BERT (C) in the nonneural ectoderm or Geminin, ERNI, and BERT (E) in the extra-embryonic epiblast and stained for
Sox2 (purple). The same embryos after staining for GFP (brown) to mark electroporated cells (D) and (F). A section of the embryo in (D) reveals that the
induced epiblast acquires a neural plate–like morphology (D9).
(G–J) Embryos electroporated with a MO against BERT (G) or a control MO (I) in the prospective neural plate and stained for Sox2 (purple). In (H) and (J),
the same embryos are stained with anti-fluorescein to detect the MO (brown).
(K and L) Embryo electroporated with the MO against BERT in the neural plate and immunostained for BERT protein (brown, [K]). (L) The same embryo
under fluorescence to show the cells electroporated with the fluorescein-labeled MO.
(M) We propose that BERT disrupts the interaction between Geminin and ERNI, displacing HP1c from the N2 enhancer and thus allowing Geminin/
Brahma to induce Sox2 expression.
doi:10.1371/journal.pbio.0060002.g009
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literature; its signiﬁcance is explored further in the following
sections.
Molecular Interactions Regulating the Timing of Gene
Expression
The N2 enhancer of Sox2 is about 550 bp long and is
predicted to contain multiple binding sites for transcription
factors [20], many of which are expressed in the epiblast prior
to the stage at which Sox2 expression is initiated. In principle,
binding of the appropriate activators to the N2 enhancer
should turn on Sox2. However, the spatial and temporal
patterns of expression of these factors do not account for the
timing or spatial distribution of Sox2 transcription at this
stage in development, as many of them are expressed
ubiquitously (unpublished data). We therefore propose that,
irrespective of the binding of putative activators to the N2
enhancer, the conformation of chromatin, maintained in a
closed conﬁguration by HP1 proteins, prevents activation at
early stages. It is only when HP1 proteins are removed and
the chromatin-remodeling activity of Brm is released that N2
is activated.
Chromatin-remodeling complexes may turn out to have a
widespread role in the transcriptional activation of speciﬁc
genes, as exempliﬁed by Smad-activated genes whose tran-
scriptional regulation also requires the activity of such
complexes [46]. Likewise during skeletal muscle differentia-
tion, chromatin-binding proteins ‘‘mark the spot’’ for
activation of genes by other transcription factors together
with chromatin remodeling by SWI/SNF proteins: MyoD
binding to chromatin is regulated by the homeodomain
protein Pbx1 in cooperation with the Brahma-related enzyme
Brg1 [47–50]. To our knowledge, however, this is the ﬁrst
report suggesting that a SWI/SNF chromatin-remodeling
complex can recruit HP1 proteins to a speciﬁc enhancer to
repress transcription of a target gene.
Mechanisms Regulating the Timing of Neural Plate
Formation
Our model proposes mutually inhibitory interactions
between several proteins. Why does Sox2 need to be regulated
by such a complex mechanism, rather than by merely
recruiting a single or a few activators to a simple enhancer?
Figure 10. Expression of BERT during Normal Development
BERT is expressed ubiquitously in the chick embryo albeit at low levels. At the end of gastrulation (A), its expression is up-regulated in the prospective
neural plate, where it becomes stronger during subsequent stages (B–D).
doi:10.1371/journal.pbio.0060002.g010
Figure 11. Direct Interactions between the Coiled-Coil Proteins
(A–C) Example of a positive interaction between BERT and itself (homodimerization). B(C): BERT-Venus(C); B(N), BERT-Venus(N).
(D and F) Example of a negative control, BERT, and another coiled-coil protein, E2F3. D(C), E2F5-Venus(C).
(A) and (D) Phase contrast, (B) and (E) fluorescence, (C) and (F) merged phase contrast and fluorescence images.
doi:10.1371/journal.pbio.0060002.g011
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We suggest that this is one in a series of steps that act to
separate different functions for signals that are common to
different developmental processes.
Previously, we showed that 3–5 h of exposure to signals
from the organizer (Hensen’s node) is sufﬁcient to induce
transient expression of the pre-neural marker Sox3, but not
sufﬁcient to induce later neural plate markers (such as Sox2),
and that the BMP antagonist Chordin can stabilize the
expression of Sox3 induced by such a graft (but again not
induce Sox2) [16]. Based on these ﬁndings, we conducted a
screen to identify genes induced within 5 h of exposure to the
organizer [36]. We identiﬁed several genes induced within this
time, among them ERNI, which is induced very rapidly, within
1–2 h. FGF8 is sufﬁcient to mimic this effect, and during
normal development, ERNI is expressed even before gastru-
lation, in a domain identical to that covered by the under-
lying hypoblast (which expresses FGF8).
FGF is required for both mesodermal [51–54] and neural
induction [36,55,56]. How do cells that have received FGF
signals decide between these two incompatible fates? A likely
scenario is that cooperation with other factors, present at
different times and in different locations, contributes to
reﬁne this choice. To allow this to happen, it may be
necessary for cells to retain a ‘‘memory’’ that they have
received FGF signals yet be prevented from being allocated
prematurely to inappropriate fates. ERNI appears to fulﬁll
Figure 12. BiFCo Competition Assays
(A and B) BERT disrupts Geminin-Venus(N)::ERNI-Venus(C) heterodimers (G(N)-E(C)). B, BERT.
(D and E) BERT-Venus(C) disrupts Geminin-Venus(N)::ERNI heterodimers through its association with Geminin-Venus(N). B(C), Bert-Venus(C); E, ERNI;
G(N), Geminin-Venus(N).
(G and H) BERT-Venus(C) disrupts Geminin::ERNI-Venus(N) heterodimers through its association with ERNI-Venus(N). B(C), BERT-Venus(C); E(N), ERNI-
Venus(N); G, Geminin.
(C), (F), and (I) are the respective controls using the noninteracting Dlx5 protein as competitor. D(C), Dlx5-Venus(C)
doi:10.1371/journal.pbio.0060002.g012
Figure 13. Interaction of Geminin, ERNI, and BERT on the N2 Enhancer
(A–D) Electroporation of GFP with N2-TK-LacZ does not activate the reporter (A), whereas electroporation of GemininþERNIþBERT with N2-TK-LacZ does
([C]; LacZ in blue). In (B) and (D), the same embryos are stained for GFP to mark the electroporated cells.
(E) ChIP assay on chromatin from E7.5 mouse neural plate, demonstrating a direct interaction between Geminin and the N2 enhancer. ab, antibody.
doi:10.1371/journal.pbio.0060002.g013
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such a role: while it is expressed, cells are multipotent, as its
early domain of expression encompasses the prospective
neural and mesendodermal domains as well as some non-
neural ectoderm. At the end of gastrulation, ERNI tran-
scription starts to be down-regulated from the future neural
plate, remaining only at the border between neural and
epidermal domains [36,57]. At the same time, BERT is up-
regulated in the domain that is losing ERNI expression while
Sox2 starts to be expressed in the same domain (stage 4–4þ).
This sequence of events could help to explain why it takes
such a long time (about 9 h) following a graft of a node for
Sox2 expression to begin and for a neural plate to be induced
[14–17]. Consistent with the proposal that ERNI is part of a
mechanism to prevent premature expression of Sox2, we have
observed that transfection of BERT into the prospective
neural plate region of stage 2–3 embryos can induce
premature expression of Sox2 (unpublished data).
The present and previous studies [36] reveal that FGF
signaling activates ERNI as well as Sox3 and Geminin
expression in the epiblast. However, FGF does not induce
BERT, whose expression is also not regulated by BMP
antagonists or any combination of known factors implicated
in neural induction to date (unpublished data). In future, it
will be interesting to determine whether BERT is induced by
some other combination of factors or whether its expression
is regulated simply by a cell-autonomous timer in cells that
are still in the epiblast at the end of gastrulation, but does not
require input from other cells.
In all likelihood, the mechanisms responsible for regulating
Sox2 expression and the acquisition of neural fate will turn
out to be considerably more complex, and our model does
not rule out additional mechanisms. It will be interesting in
future to investigate whether other developmentally ex-
pressed genes are regulated by similar processes.
Conclusions
Our ﬁndings provide a mechanism for how Sox2 expression
is initiated as part of the events that deﬁne the early neural
plate. We propose that ERNI functions as an inhibitor of
premature Sox2 expression during early gastrulation: cells
expressing ERNI are multipotent and can generate any cell
type. Cells that remain in the epiblast at the end of
gastrulation and acquire expression of BERT to activate
Sox2, which, most likely together with other genes involved in
neural speciﬁcation, assigns a neural plate fate.
Materials and Methods
Chick experiments. Fertile hens’ eggs (Brown Bovan Gold; Henry
Stewart & Co.) were incubated at 38 8C to the desired stages.
Electroporations were performed as described [35]. The coding
region of full-length ERNI, ERNI coiled-coil domain (aa 1–164), chick
BERT, chick Geminin, human BrmK755R (kind gift from Dr A
Imbalzano), mouse HP1a, mouse HP1a chromoshadow domain (aa
106–180), and mouse HP1c chromoshadow domain (aa 118–176) were
cloned into pCAb and electroporated at 0.2 lg/ll (except ERNI and
BrmK755R and HP1a, which were used at 0.4 lg/ll) together with 1 lg/
ll of pCAb-GFP, which was used to mark the electroporated cells. The
N2-TK-LacZ reporter plasmid was constructed from N2-TK-GFP,
kindly provided by Dr H. Kondoh, and was electroporated at 1 lg/ll.
FGF8b (Sigma) was delivered bound to heparin beads (prepared as
described [19]) at 50 lg/ml. In situ hybridization and immunostaining
for GFP were performed as described [35].
Design of assays. To establish the role of different components in
regulating the expression of Sox2, three different types of assays were
used for gain- and loss-of-function experiments. First, to assess the
effects on endogenous expression of Sox2 in the normal neural plate,
constructs were introduced into the prospective neural plate at mid-
primitive streak stage (stage 3–3þ) and the embryos incubated about 6–
9 h so that the embryo had reached stages 4þ–7, just beyond the stages
at which Sox2 expression begins (4þ) and also because at these stages
the neural plate is still open, allowing easier visualization of expanded
expression. Please note that stages 4þ–7 are particularly short, this
entire period lasting only about 3 6 1.5 h at 38 8C. To determine
whether a construct can induce ectopic expression of Sox2, two
different locations were chosen. In one set of assays, the construct is
introduced as a continuous line between the prospective neural plate
of the embryo and the inner aspect of the extraembryonic epiblast,
covering most of the prospective epidermis. In the other assay, the
construct is introduced as a discrete domain within the inner third of
the extraembryonic (area opaca) epiblast and the embryos incubated
12–15 h (by which time they have reached stages 6–9).
The reasons for choosing both of the latter two assays for
induction is that extensive embryological studies have revealed
differences in their reactivity to neural inducing stimuli. For
example, inhibition of BMP signaling is sufﬁcient to expand the
endogenous neural plate laterally (and BMP misexpression to narrow
it), but only when the territory is continuous with the embryo’s own
neural plate [13,16,17], suggesting that induction of neural markers
by certain stimuli in this region requires cellular continuity with the
neural plate and/or its border. On the other hand, a graft of the
organizer (Hensen’s node) is able to induce a complete, patterned
ectopic nervous system from the extraembryonic epiblast of the inner
area opaca [13,29–32]. A period of 9–13-h contact is required to
induce Sox2 after a graft of the organizer, which is why 12–15 h was
chosen in this assay. To date, no single factor or any combination
thereof has been found to mimic this activity of the organizer. It is
therefore particularly important, to assess the full inducing proper-
ties of a treatment, to test its ability to induce Sox2 in the area opaca.
We therefore used all three assays to compile a more comprehensive
understanding of the inducing or inhibiting activities of each of the
constructs in this study.
Morpholino experiments. A translation-blocking MO against BERT
with the sequence CAGCGTCCATGTCAGCGTTCATCAT, targeting
the 59 end of the ORF of the gene or a standard control MO (Gene
Tools LLC), both labeled with ﬂuorescein, were electroporated by
injecting a small volume (about 0.1 ll) of a stock of the MO at 1 mM
exactly as described for electroporation of constructs (see above).
Antibody against human SCOCO was kindly provided by Dr. Richard
Kahn. This was used in whole mounts by indirect immunoperoxidase
with anti-rabbit-HRP using the same method as described for GFP
(see above).
Two-hybrid screens. For two-hybrid screens with embryonic
cDNA, poly-A RNA was isolated from 600 chick embryos (stage 3–6)
using the Ambion Poly(A)Pure Kit. The mRNA was used to synthesize
a cDNA library which was cloned into the pMyr vector using the
CytoTrap XR Library Construction Kit (Stratagene). The library was
transformed into XL10-Gold Ultracompetent Cells (Stratagene). Full-
length ERNI was cloned into the pSOS vector and used as bait in the
CytoTrap two-hybrid screen, which was performed according to the
manufacturer’s instructions (Stratagene).
For two-hybrid screens on chick ES cells, poly-A RNA was isolated
from ES cells [58]. cDNA was synthesized using Stratagene’s cDNA
synthesis kit and introduced into pGAD424 vector (Clontech), and this
was transformed into XL1-blue MRF’ bacteria by electroporation. All
plasmids, yeast strains, and media used were purchased from
Clontech. The bait ENS-1/ERNI coding sequence was cloned in
NdeI/SalI sites of pGBKT7, introduced into AH109 yeast, and checked
for lack of self-activation of the reporter. Screening was performed
according to the Yeast Protocols Handbook (Clontech). pGAD424
recombinant plasmids from 18 candidates were puriﬁed, of which
seven encoded the CHCB2 protein [41] and all included the
chromoshadow domain. The smallest one, encoding the 87 carboxy-
terminal amino acids, was used in further experiments. The full ENS-
1/ERNI coding sequence was cloned into pGADT7 and various
truncated forms (Figure 5) subcloned into pGBKT7. Point mutations
were introduced into pGBKT7:ENS-1 using the QuikChange site-
directed mutagenesis kit from Stratagene and checked by sequencing.
Yeast two-hybrid assays were performed by rapid cotransformation
of strain AH109.
Cloning of chick Geminin. The Xenopus Geminin amino acid
sequence was used to BLAST the GenBank EST database. The full-
length chick homolog sequence was recovered and cloned by PCR
from the CytoTrap cDNA library described above.
BiFCo experiments. The N- and C-terminal halves of Venus (aa 1–
154 and 155–229) were PCR-ampliﬁed from pCS2 vectors and cloned
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into pcDNA3.1A. Geminin, ERNI, BERT, and human E2F3 were cloned
in frame into the 59 end of each of the two Venus halves, giving rise to
six plasmids expressing each of the three genes fused to either of the
two Venus halves. Dlx5 control vectors were a kind gift of Andrew
Bailey. COS cells and cES cells were transfected as described [16], and
the cells were observed the next day by epiﬂuorescence in a
compound microscope.
ChIP assay. The method used closely followed one previously
described [59]. Brieﬂy, 20 E7.5 mouse embryos were ﬁxed in 4%
formaldehyde, homogenized in lysis buffer, and sonicated. Cell
extracts were harvested by centrifugation, incubated overnight with
an antibody against mouse Geminin (Santa Cruz Biotechnology FL-
209, 5 lg), and then immunoprecipitated with Protein-A-Sepharose.
Precipitates were heated to reverse the formaldehyde cross-linking.
The DNA fragments in the precipitates were puriﬁed by phenol/
chloroform extraction and EtOH precipitation and used as a
template for a PCR, using the following mouse N2-speciﬁc primers:
f o rw a r d : AACTCTCATAGCCCTAACTGTC , r e v e r s e :
CCCTCCTCTCCTAATCTCCTTATGG. After 20 cycles of ampliﬁca-
tion, one-tenth of the reaction product was used as a template for a
second round of a further 20 cycles. The ﬁnal PCR products were run
on a 1% agarose gel.
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